75F40119D10015-75F40123F19094
Delivery Order
Overview
Government Description
To obtain bioinformatics services to support the development of an internal bioinformatics validation pipeline targeting neoantigen cancer vaccine development. These efforts will support the regulatory program of the dct in otp/cber/FDA.
Awardee
Awarding / Funding Agency
Place of Performance
Silver Spring, MD 20993 United States
Pricing
Labor Hours
Set Aside
8(A) Sole Source (8AN)
Extent Competed
Not Available For Competition
Related Opportunity
(Parent Award)
1216662
Analysis Notes
Vulnerable Incumbent Midnight Sun Technologies is listed as graduating from the 8(a) program in July 2024, which may limit its ability to recompete.
DOGE This delivery order was on the Department of Government Efficiency (DOGE) termination list as of July 2025. See All
Termination This delivery order was terminated for convenience (partial or complete) in April 2025.
Sole Source This Delivery Order was awarded sole source to Midnight Sun Technologies because the government was authorized to sole source the contract by statute to a certified 8(a) firm for a contract estimated at award to be <$7.0 million.
DOGE This delivery order was on the Department of Government Efficiency (DOGE) termination list as of July 2025. See All
Termination This delivery order was terminated for convenience (partial or complete) in April 2025.
Sole Source This Delivery Order was awarded sole source to Midnight Sun Technologies because the government was authorized to sole source the contract by statute to a certified 8(a) firm for a contract estimated at award to be <$7.0 million.
Midnight Sun Technologies was awarded
Delivery Order 75F40123F19094 (75F401-23-F-19094)
worth up to $344,486
by the FDA Office of Acquisition and Grant Services
in August 2023.
The contract
has a duration of 2 years 1 months and
was awarded
with a 8(a) Sole Source set aside
with
NAICS 541690 and
PSC R499
via sole source acquisition procedures.
Status
(Complete)
Last Modified 4/1/25
Period of Performance
8/11/23
Start Date
9/12/25
Current End Date
9/12/25
Potential End Date
Obligations
$344.5K
Total Obligated
$344.5K
Current Award
$344.5K
Potential Award
Award Hierarchy
Indefinite Delivery Contract
Delivery Order
75F40119D10015-75F40123F19094
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for 75F40119D10015-75F40123F19094
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2024 | $172,541 | 1,849.0 | 0.9 | $93.32 |
Transaction History
Modifications to 75F40119D10015-75F40123F19094
People
Suggested agency contacts for 75F40119D10015-75F40123F19094
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Authorized By Statute
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
ZKR5F6EZNAD2
Awardee CAGE
7DG52
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsrobert_waite
Last Modified By
hhspframe
Approved By
hhspframe
Legislative
Legislative Mandates
Labor Standards
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| FDA Innovation, CURES Act, Food and Drug Administration, Health and Human Services (075-5629) | Consumer and occupational health and safety | Advisory and assistance services (25.1) | $172,243 | 100% |
Modified: 4/1/25